During the past decade, Hospital Maria Auxiliadora conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Maria Auxiliadora" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Mallinckrodt" with 2 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored and "Eske Corporation S.A.C" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Maria Auxiliadora" #1 collaborator was "Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH)" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Genmab" with 1 trials as a collaborator and "Sociedad Interamericana de Cardiología (SIAC)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Maria Auxiliadora" are "Influenza" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Breast Cancer Stage IIIA" (1 trials), "Breast Cancer Stage IV" (1 trials) and "Breast Cancer, Stage IIIB" (1 trials). Many other conditions were trialed in "Hospital Maria Auxiliadora" in a lesser frequency.

Most popular intervention types in "Hospital Maria Auxiliadora" are "Drug" (14 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Acthar Gel" (2 trials), "Cyclophosphamide" (2 trials), "Methylprednisolone" (2 trials) and "Tocilizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Maria Auxiliadora" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Maria Auxiliadora". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital Maria Auxiliadora, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Maria Auxiliadora, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".